Andrew Bate

9.7k total citations · 3 hit papers
122 papers, 6.2k citations indexed

About

Andrew Bate is a scholar working on Toxicology, Statistics and Probability and Economics and Econometrics. According to data from OpenAlex, Andrew Bate has authored 122 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Toxicology, 28 papers in Statistics and Probability and 23 papers in Economics and Econometrics. Recurrent topics in Andrew Bate's work include Pharmacovigilance and Adverse Drug Reactions (61 papers), Statistical Methods in Clinical Trials (23 papers) and Computational Drug Discovery Methods (20 papers). Andrew Bate is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (61 papers), Statistical Methods in Clinical Trials (23 papers) and Computational Drug Discovery Methods (20 papers). Andrew Bate collaborates with scholars based in United Kingdom, United States and Sweden. Andrew Bate's co-authors include Roland Orre, I. Ralph Edwards, Marie Lindquist, Stephen Evans, G. Niklas Norén, Eugène van Puijenbroek, Hubert G.M. Leufkens, Toine C. G. Egberts, Anders Lansner and Sten Olsson and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Nature Reviews Drug Discovery.

In The Last Decade

Andrew Bate

116 papers receiving 6.0k citations

Hit Papers

A Bayesian neural network method for adverse drug reactio... 1998 2026 2007 2016 1998 2002 2009 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Bate United Kingdom 34 3.5k 1.3k 1.1k 834 804 122 6.2k
Marie Lindquist Sweden 24 2.5k 0.7× 840 0.7× 860 0.8× 458 0.5× 538 0.7× 45 3.9k
Patrick Ryan United States 49 1.4k 0.4× 689 0.5× 509 0.5× 1.2k 1.5× 431 0.5× 217 8.7k
Martijn J. Schuemie United States 48 1.1k 0.3× 502 0.4× 566 0.5× 951 1.1× 385 0.5× 194 8.5k
Johan van der Lei Netherlands 40 670 0.2× 253 0.2× 410 0.4× 306 0.4× 319 0.4× 174 6.5k
A. Lawrence Gould United States 35 366 0.1× 201 0.2× 256 0.2× 1.2k 1.4× 361 0.4× 99 5.1k
Gerald J. Dal Pan United States 30 598 0.2× 115 0.1× 208 0.2× 391 0.5× 501 0.6× 106 4.1k
Nicole Pratt Australia 38 492 0.1× 200 0.2× 346 0.3× 327 0.4× 226 0.3× 214 6.6k
Byung‐Joo Park South Korea 45 400 0.1× 100 0.1× 633 0.6× 106 0.1× 274 0.3× 317 7.5k
Michael E. Matheny United States 52 273 0.1× 296 0.2× 171 0.2× 143 0.2× 220 0.3× 265 9.7k
David Madigan United States 24 528 0.2× 269 0.2× 134 0.1× 427 0.5× 113 0.1× 47 2.6k

Countries citing papers authored by Andrew Bate

Since Specialization
Citations

This map shows the geographic impact of Andrew Bate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Bate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Bate more than expected).

Fields of papers citing papers by Andrew Bate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Bate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Bate. The network helps show where Andrew Bate may publish in the future.

Co-authorship network of co-authors of Andrew Bate

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Bate. A scholar is included among the top collaborators of Andrew Bate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Bate. Andrew Bate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Haguinet, François, et al.. (2024). Tree‐temporal scan statistics for safety signal detection in vaccine clinical trials. Pharmaceutical Statistics. 23(6). 813–836. 1 indexed citations
3.
Osborne, Vicki, Amie Goodin, Joshua D. Brown, et al.. (2024). Updated core competencies in pharmacoepidemiology to inform contemporary curricula and training for academia, government, and industry. Pharmacoepidemiology and Drug Safety. 33(4). e5789–e5789.
7.
Mahaux, Olivia, et al.. (2023). Identifying Safety Subgroups at Risk: Assessing the Agreement Between Statistical Alerting and Patient Subgroup Risk. Drug Safety. 46(6). 601–614. 5 indexed citations
8.
Gatto, Nicolle M., Shirley Wang, William Murk, et al.. (2022). Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting. Pharmacoepidemiology and Drug Safety. 31(11). 1140–1152. 8 indexed citations
9.
Kompa, Benjamin, Joe B. Hakim, Anil Palepu, et al.. (2022). Artificial Intelligence Based on Machine Learning in Pharmacovigilance: A Scoping Review. Drug Safety. 45(5). 477–491. 41 indexed citations
10.
Bate, Andrew, et al.. (2020). PNS271 Automation in Routine Use for Data Collection and Processing for Scalable Faster RWE Generation. Value in Health. 23. S686–S686. 4 indexed citations
11.
Sobel, Rachel E., William L. Blackwell, David Fram, & Andrew Bate. (2019). A Novel Approach to Visualize Risk Minimization Effectiveness: Peeping at the 2012 UK Proton Pump Inhibitor Label Change Using a Rapid Cycle Analysis Tool. Drug Safety. 42(11). 1365–1376. 1 indexed citations
12.
Brauer, Ruth, Ian Douglas, Luis A. Garcı́a Rodrı́guez, et al.. (2016). Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case–control studies using two primary care databases in Europe. Pharmacoepidemiology and Drug Safety. 25(S1). 29–38. 13 indexed citations
13.
Wisniewski, A, Andrew Bate, Cédric Bousquet, et al.. (2016). Good Signal Detection Practices: Evidence from IMI PROTECT. Drug Safety. 39(6). 469–490. 106 indexed citations
14.
Bate, Andrew & Gavin Lowe. (2012). A Debugger for Communicating Scala Objects. Oxford University Research Archive (ORA) (University of Oxford). 135–154.
15.
Bate, Andrew & Frank M. Hilker. (2011). Rabbits protecting birds: Hypopredation and limitations of hyperpredation. Journal of Theoretical Biology. 297. 103–115. 14 indexed citations
16.
Strandell, Johanna, Andrew Bate, Staffan Hägg, & I. Ralph Edwards. (2009). Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction. British Journal of Clinical Pharmacology. 68(3). 427–434. 41 indexed citations
17.
Bate, Andrew, et al.. (2008). The application of knowledge discovery in databases to post‐marketing drug safety: example of the WHO database. Fundamental and Clinical Pharmacology. 22(2). 127–140. 73 indexed citations
18.
Bate, Andrew. (2007). Bayesian Confidence Propagation Neural Network. Drug Safety. 30(7). 623–625. 82 indexed citations
19.
Orre, Roland, et al.. (2003). A Bayesian recurrent neural network approach for finding dependencies in large incomplete data sets. International Journal of Neural Systems. 2 indexed citations
20.
Bate, Andrew, Marie Lindquist, Roland Orre, I. Ralph Edwards, & R.H.B. Meyboom. (2002). Data-mining analyses of pharmacovigilance signals in relation to relevant comparison drugs. European Journal of Clinical Pharmacology. 58(7). 483–490. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026